Benign prostatic hyperplasia
Current Care Summary |  Published: 2018-11-07  
Working group appointed by the Finnish Medical Society Duodecim and the Finnish Urological Association
Print

Benign prostatic hyperplasia

Current Care Summary
7.11.2018
Working group appointed by the Finnish Medical Society Duodecim and the Finnish Urological Association

Current Care Guideline in Finnish «Eturauhasen hyvänlaatuinen liikakasvu»1 and Summary «Eturauhasen hyvänlaatuinen liikakasvu»2 in Finnish

Most benign prostatic hyperplasia (BPH) patients can be diagnosed and treated in primary care. Evaluation requires a history, a symptom score (DAN-PSS or IPSS) and a careful physical examination including a digital rectal examination. Careful follow-up and medical therapy are the usual first-line management options in uncomplicated BPH. Combination therapy with both alpha-blocker and 5alpha-reductase inhibitor is the most effective medical treatment modality. Transurethral resection (TURP) is a safe and effective way of treating BPH. The green laser is an endoscopic treatment option for TURP or open resection.

Teuvo Tammela

Pekka Kinnala

Anssi Pétas

Hanna Ronkainen

Raija Sipilä

Kimmo Taari

Current Care Guidelines are independent, evidence-based clinical practice guidelines. These national guidelines cover important issues related to Finnish health, medical treatment as well as prevention of diseases. Learn more